Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten(R)
23 Janeiro 2007 - 10:00AM
Business Wire
Akorn, Inc. (AMEX: AKN) today announced the positive results of a
Phase III pivotal trial for Akten�. The clinical trial was a
randomized, placebo controlled, multi-centered, 4-arm trial in 209
subjects. The primary efficacy end point for achieving ocular
anesthesia (p
Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AMEX:AKN)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AMEX:AKN)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product da American Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Akorn, Inc.